Transmission-based Precautions I: Contact, Enteric, and Droplets
Healthcare Associated Infections II: Preventive Measures
Peptic Ulcer Disease IV: Management
Standard Precaution
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Standards of Care II
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 18, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Megan R Undeberg1, Dana R Bowers2, Kimberly C McKeirnan1
11Washington State University College of Pharmacy and Pharmaceutical Sciences, Pharmacotherapy Department, Spokane, Washington.
Recurrent Clostridioides difficile infection (CDI) requires careful management. Pharmacists play a key role in selecting effective treatments and reviewing guidelines for optimal patient outcomes.
Area of Science:
Background: